"Prophylaxis for Second Eye Involvement in Leber Hereditary Optic Neuropathy: An Open-Labeled, Nonrandomized Multicenter Trial of Topical Brimonidine Purite" by Nancy J. Newman

Selected Works of Steven R. Hamilton, MD

Article

Prophylaxis for Second Eye Involvement in Leber Hereditary Optic Neuropathy: An Open-Labeled, Nonrandomized Multicenter Trial of Topical Brimonidine Purite

American Journal of Ophthalmology (2005)

Nancy J. Newman, Emory University
Valerie Biousse, Emory University
Robert David, Allergan Inc, Irvine, California
M. Tariq Bhatti, University of Florida
Steven R. Hamilton, Swedish Neuroscience Institute, Seattle, Washington
Bradley K. Farris, Dean A. McGee Eye Institute, Oklahoma City, Oklahoma
Robert L. Lesser, Yale University
Steven A. Newman, University of Virginia
Roger E. Turbin, University of Medicine and Dentistry of New Jersey
Kuankuan Chen, Allergan Inc, Irvine, California
Robert P. Keaney, Allergan Inc, Irvine, California

Link

Disciplines

Publication Date

September 1, 2005

DOI

10.1016/j.ajo.2005.03.058

Citation Information

Nancy J. Newman, Valerie Biousse, Robert David, M. Tariq Bhatti, et al.. "Prophylaxis for Second Eye Involvement in Leber Hereditary Optic Neuropathy: An Open-Labeled, Nonrandomized Multicenter Trial of Topical Brimonidine Purite" American Journal of Ophthalmology Vol. 140 Iss. 3 (2005) p. 407 - 415
Available at: http://works.bepress.com/steven-hamilton/7/